Your Health, We Care
Asciminib is a targeted inhibitor of BCR-ABL1 tyrosine kinase, mainly used for the treatment of blood diseases such as chronic myeloid leukemia (CML), initially developed and produced by Novartis.
The Asciminib drug developed and produced by Lucius has a specification of 40mg * 60tablets and a price of approximately $621 per box. The drug price may vary due to factors such as region, sales channels, and promotional activities.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
